Latest Publications

Share:

MBHB Snippets: Review of Developments in Intellectual Property Law - Winter 2013 - Volume 11, Issue 1: Federal Courts Debate Safe...

Patent protection is a critical driver of value for the biotech industry. One of the unique aspects of biotech patents, however, is that many otherwise infringing activities are exempt from claims of patent infringement when...more

2/19/2013 - ANDA Biotechnology Exemptions FDA Infringement Integra Merck Patents Research Tools Safe Harbors

MBHB Snippets: Review of Developments in Intellectual Property Law - Winter 2013 - Volume 11, Issue 1

In This Issue: Federal Courts Debate Safe Harbor Exemption for Patent Infringement Under 35 U.S.C. ยง 271(e) Following Merck v. Integra; If I Prioritize Examination of My Application, Should the Patent Office?;...more

2/19/2013 - Biotechnology Discovery Exemptions FDA Hatch-Waxman Infringement Integra InterDigital Communications v ITC Merck Non-Practicing Entities Patent Litigation Patents Pharmaceutical Prioritized Examination Safe Harbors

2 Results
|
View per page
Page: of 1